Stockman: "Also, Professor Masters who was in charge of the Alzheimers trial back then, just licensed our formula exclusively for AZ. Why would Professor Masters waste his time again if he thought our drug was a flop"?
Prof Masters licensed the same old molecule PBT2 that failed and not ATH434. He seems to be very sure that PBT2 works. It is a zinc chelator but also an iron chelator, but less iron chelator than ATH434.
Stockman: "Also, Professor Masters who was in charge of the...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $501.4K | 91.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 71 | 70438990 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 7499794 | 14 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
-0.001 ( 8.33 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.6¢ | 3568393 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| ATH (ASX) Chart |